Creating a DNA bank for congenital heart disease in southeastern France
Official title: Creation of a French South-Eastern Database and DNA-bank of Congenital Heart Disease to Explore the Genetic Pathways
Run by Assistance Publique Hopitaux De Marseille · NCT02923440 · Data updated 2026-11-12
This study is creating a DNA bank for people with congenital heart defects in southeastern France to help understand the genetic causes of these conditions better.
Quick facts
| Study type | Interventional |
|---|---|
| Sex | All |
| Enrollment | 300 (estimated) |
| Sponsor | Assistance Publique Hopitaux De Marseille Academic / other |
| Locations | 1 site (Marseille) |
| Status | Recruiting |
| Started | January 17, 2017 |
| Main results expected | January 2028 |
| Study ends | March 2028 |
| Registry record updated | March 13, 2023 |
| Trial ID | NCT02923440 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include newborns diagnosed with congenital heart defects who require a blood test as part of their medical care.
✕Probably not a fit
Patients who are pregnant or those unable to provide informed consent due to mental or physical incapacity may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This project aims to establish a comprehensive DNA bank specifically for patients with congenital heart defects in the south-eastern region of France. By collecting blood samples from affected individuals, the study seeks to enhance the understanding of the genetic pathways involved in these conditions. The initiative addresses the lack of local resources for genetic research and aims to facilitate better diagnosis and classification of congenital heart diseases. The study will utilize the existing infrastructure at the Assistance Publique Hopitaux de Marseille for sample collection and analysis.
Why it matters
Potential benefit: If successful, this initiative could lead to improved genetic understanding and management of congenital heart defects, ultimately benefiting affected patients.
How similar studies have gone: While similar DNA banks have been established in other regions, this specific initiative is novel for the south-eastern region of France.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Echocardiographic diagnosis of congenital heart defect falling within the classification Houyel and Bonnet * Necessity of making a blood test regardless of study * Medical care in the AP-HM Timone Hospital children, medical-surgical unit of pediatric and congenital cardiology, Marseille - These Parent Child Exclusion Criteria: * Pregnant women * Patients or parent / legal guardian (if minor) in physical or mental incapacity to understand or sign the consent * People in Emergencies * Persons deprived of freedom * Persons not beneficiaries of a social security scheme * Persons in health or social institution
Where it's running
-
Assistance Publique Hopitaux de Marseille
Marseille, France Recruiting
Study contacts
- Study coordinator: Caroline Ovaert
- Email: caroline.ovaert@ap-hm.fr
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Pulmonary Artery Growth in Tetralogy of Fallot: A Look at Nakata Index Over Time
This study tests how pulmonary artery sizes change from birth through surgery in kids with Tetralogy of Fallot to see if the Nakata index can help guide treatment.
-
Partial versus complete thymus removal during infant heart surgery
This will test whether removing only part of the thymus instead of the whole gland during heart surgery helps preserve immune function in infants under 6 months.
-
Understanding neurodevelopmental disorders in children with congenital heart defects
This study is trying to see how heart surgery in young children with serious heart defects affects their brain development and behavior as they grow up.
-
Understanding the genetics of heterotaxy and congenital heart defects
This study is trying to learn more about the genetics behind heterotaxy syndrome and congenital heart defects by collecting information and samples from affected individuals and their families.
-
Pediatric Cardiac Oxygenation Monitoring During Open-Heart Surgery
This study tests whether the SpectroCor Tissue Oxygenation Monitor and its Sensor can track heart tissue oxygen levels in children undergoing open-heart surgery.
-
High-flow nasal cannula versus non-invasive ventilation after extubation in children following heart surgery
This compares high-flow nasal cannula and non-invasive ventilation to see which better prevents reintubation in children after heart surgery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.